110 related articles for article (PubMed ID: 35847007)
1. Developing a Core Outcome Set for Assessing Clinical Safety Outcomes of Prostate Cancer in Clinical Trials of Traditional Chinese Medicine: Protocol for a Mixed Methods Study.
Tian H; Zhang Y; Ren J; Wang C; Mou R; Li X; Jia Y
JMIR Res Protoc; 2023 Aug; 12():e46794. PubMed ID: 37549007
[TBL] [Abstract][Full Text] [Related]
2. A New Therapeutic Trend: Natural Medicine for Ameliorating Ischemic Stroke via PI3K/Akt Signaling Pathway.
Liu X; Xiao X; Han X; Yao L; Lan W
Molecules; 2022 Nov; 27(22):. PubMed ID: 36432062
[TBL] [Abstract][Full Text] [Related]
3. Astragaloside IV derived from Astragalus membranaceus: A research review on the pharmacological effects.
Zhang J; Wu C; Gao L; Du G; Qin X
Adv Pharmacol; 2020; 87():89-112. PubMed ID: 32089240
[TBL] [Abstract][Full Text] [Related]
4. Review of the pharmacological effects of astragaloside IV and its autophagic mechanism in association with inflammation.
Yang Y; Hong M; Lian WW; Chen Z
World J Clin Cases; 2022 Oct; 10(28):10004-10016. PubMed ID: 36246793
[No Abstract] [Full Text] [Related]
5. Astragalus-Scorpion Drug Pair Inhibits the Development of Prostate Cancer by Regulating GDPD4-2/PI3K/AKT/mTOR Pathway and Autophagy.
You X; Wu Y; Li Q; Sheng W; Zhou Q; Fu W
Front Pharmacol; 2022; 13():895696. PubMed ID: 35847007
[No Abstract] [Full Text] [Related]
6. [Explore the mechanism of astragaloside IV-PESV on proliferation, migration, and autophagy of prostate cancer cells based on the PI3K/AKT signaling pathway].
You XJ; Wen Z; Zheng QX; Li QX; Fu W; Li HS; Wang B
Zhonghua Nan Ke Xue; 2023 Dec; 29(12):963-972. PubMed ID: 38639947
[TBL] [Abstract][Full Text] [Related]
7. Astragaloside IV alleviates Schwann cell injury in diabetic peripheral neuropathy by regulating microRNA-155-mediated autophagy.
Yin Y; Qu H; Yang Q; Fang Z; Gao R
Phytomedicine; 2021 Nov; 92():153749. PubMed ID: 34601220
[TBL] [Abstract][Full Text] [Related]
8. Astragaloside IV-PESV inhibits prostate cancer tumor growth by restoring gut microbiota and microbial metabolic homeostasis via the AGE-RAGE pathway.
You X; Qiu J; Li Q; Zhang Q; Sheng W; Cao Y; Fu W
BMC Cancer; 2024 Apr; 24(1):472. PubMed ID: 38622523
[TBL] [Abstract][Full Text] [Related]
9. Exploring the Pharmacological Mechanisms of Xihuang Pills Against Prostate Cancer
Wu Y; You X; Lin Q; Xiong W; Guo Y; Huang Z; Dai X; Chen Z; Mei S; Long Y; Tian X; Zhou Q
Front Pharmacol; 2021; 12():791269. PubMed ID: 35342388
[No Abstract] [Full Text] [Related]
10. Astragaloside IV Protects from PM2.5-Induced Lung Injury by Regulating Autophagy via Inhibition of PI3K/Akt/mTOR Signaling in vivo and in vitro.
Pei C; Wang F; Huang D; Shi S; Wang X; Wang Y; Li S; Wu Y; Wang Z
J Inflamm Res; 2021; 14():4707-4721. PubMed ID: 34557015
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of PI3K/AKT/mTOR Signalling Pathway Activates Autophagy and Suppresses Peritoneal Fibrosis in the Process of Peritoneal Dialysis.
Jia M; Qiu H; Lin L; Zhang S; Li D; Jin D
Front Physiol; 2022; 13():778479. PubMed ID: 35309056
[TBL] [Abstract][Full Text] [Related]
12. Linc01513 inhibits the malignant potential of Nasopharyngeal carcinoma by binding to PTBP1.
Wang J; Cai X; Zhang L; Lei D
J Cancer; 2021; 12(24):7380-7389. PubMed ID: 35003358
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
